|
|
Volumn 147, Issue 6, 2014, Pages 1433-1435
|
|
Etrolizumab in ulcerative colitis: Tightening leukocyte traffic control in the inflamed mucosa: Comment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL ADHESION MOLECULE;
CORTICOSTEROID;
CYTOKINE;
ETROLIZUMAB;
IMMUNOMODULATING AGENT;
INTEGRIN;
NATALIZUMAB;
PLACEBO;
UVOMORULIN;
VEDOLIZUMAB;
MONOCLONAL ANTIBODY;
B LYMPHOCYTE;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL HOMING;
CELL MIGRATION;
COLON BIOPSY;
CORTICOSTEROID THERAPY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
GENE EXPRESSION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INJECTION SITE REACTION;
INTESTINE MUCOSA;
LEUKOCYTE MIGRATION;
MAYO CLINIC SCORE;
NOTE;
OPPORTUNISTIC INFECTION;
OUTCOME ASSESSMENT;
PHASE 2 CLINICAL TRIAL (TOPIC);
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECTUM HEMORRHAGE;
REMISSION;
SCORING SYSTEM;
TREATMENT RESPONSE;
ULCERATIVE COLITIS;
COLITIS, ULCERATIVE;
FEMALE;
MALE;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
COLITIS, ULCERATIVE;
FEMALE;
HUMANS;
MALE;
|
|
EID: 84913595769
PISSN: 00165085
EISSN: 15280012
Source Type: Journal
DOI: 10.1053/j.gastro.2014.10.018 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|